drugset
drugset / Trial / NCT04774809

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

NCT04774809 ↗

Phase 2/3 Terminated 75 enrolled Reistone Biopharma Company Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of SHR0302 ointment in adult patients with Vitiligo.

Timeline

Start
2020-01-29
Primary completion
2022-03-21
Completion
2022-03-21

Outcome

Outcome not reported

Stopped: “terminated by sponsor”

Drugs

EvaluationDrugModalityDoseRoute
Comparator SHR0302 Unknown — —

Indications

vitiligo